EphA3 was expressed in the stromal and vascular tissues of human tumours and prostate mouse xenografts, where its treatment with anti-EphA3 mAb IIIA4 inhibited tumour growth, suggesting EphA3 as a novel target for the selective targeting of the tumour microenvironment [42]. This evidence concerns the gene EPHA3 and neoplasm.